Video: Adrenergic Agonists: Mixed-Action Agents

Mixed-acting adrenergic agonists act directly by stimulating adrenoceptors and indirectly by releasing stored catecholamines from the nerve terminals.

Unlike endogenous catecholamines, mixed-acting agonists lack a catechol moiety, making them poor substrates for metabolizing enzymes, increasing their duration of action.

Both ephedrine and pseudoephedrine exhibit excellent oral bioavailability and CNS penetration but are less potent than catecholamines.

Ephedrine—isolated from the Ephedra plant—has been used as an orally active sympathomimetic for treating asthma.

As ephedrine causes cardiac stimulation and vasoconstriction, it is used for treating anesthesia-induced hypotension. However, it is a less potent bronchodilator than isoprenaline or adrenaline.

Additionally, its central stimulatory effects are responsible for its abuse as a performance enhancer.

Pseudoephedrine—an ephedrine isomer with more indirect action—is orally effective and has fewer CNS effects. It is mainly used as a decongestant.

As it is commonly used as a precursor in illegal methamphetamine production, its sale is strictly regulated.

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.

Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by prior treatment with catecholamine-depleting agents like guanethidine or reserpine.

Ephedrine, the first orally active sympathomimetic, is used for asthma and nasal congestion. However, its potential for secondary abuse and the availability of safer alternatives have limited its use. Pseudoephedrine is primarily used as a nasal decongestant but is strictly regulated due to its potential for the illicit synthesis of methamphetamine.

Tags

Adrenergic Agonists Mixed action Agents Ephedrine Pseudoephedrine Adrenoceptors Neurotransmitters Oral Bioavailability Lipophilicity Duration Of Action Sympathomimetic Asthma Treatment Nasal Congestion Secondary Abuse Nasal Decongestant Methamphetamine Synthesis

From Chapter 6:

article

Now Playing

6.7 : Adrenergic Agonists: Mixed-Action Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

519 Views

article

6.1 : Adrenergic Neurons: Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.9K Views

article

6.2 : Adrenergic Receptors (Adrenoceptors): Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.8K Views

article

6.3 : Adrenergic Receptors: ɑ Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Views

article

6.4 : Adrenergic Receptors: β Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.5 : Adrenergic Agonists: Direct-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.1K Views

article

6.6 : Adrenergic Agonists: Indirect-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Views

article

6.8 : Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.3K Views

article

6.9 : Adrenergic Agonists: Therapeutic Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

499 Views

article

6.10 : Adrenergic Agonists: Therapeutic Uses

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

591 Views

article

6.11 : Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

651 Views

article

6.12 : Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

408 Views

article

6.13 : Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

385 Views

article

6.14 : Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

402 Views

article

6.15 : Adrenergic Antagonists: ɑ and β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

309 Views

See More

Copyright © 2025 MyJoVE Corporation. All rights reserved